Internationally benchmarked foundation for Clinical Trial

Expert Team & Research Capacity

Vinmec–VinUni brings together leading medical experts and scientists, including professors, PhDs, and board-certified specialists trained at top medical centers worldwide, with strong records of international publications. All research personnel at Vinmec–VinUni are thoroughly trained in Good Clinical Practice (GCP) through official training programs on “Good Clinical Practice in Clinical Trials” and “Safety Reporting in Clinical Drug Trials” organized by the Ministry of Health prior to participating in research activities. This ensures that Vinmec–VinUni maintains a highly qualified workforce capable of conducting clinical trials in full compliance with standardized procedures while safeguarding participant safety.

Beyond strong academic credentials, the Vinmec–VinUni team possesses extensive experience in multi-center and multinational clinical trials and has successfully hosted numerous international audits and inspections, including those conducted by the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan.

Research activities at Vinmec span a wide range of therapeutic areas, including:

• Infectious diseases: COVID-19 vaccines
• Oncology: Lung cancer, prostate cancer, liver cancer, and others
• Rare diseases: Systemic sclerosis, autoimmune myositis, lupus nephritis
• Respiratory diseases: Asthma, chronic obstructive pulmonary disease (COPD)
• Neurology: Traumatic brain injury, stroke
• Other internal medicine conditions: Heart failure, renal failure, hypertension

Vinmec–VinUni experts have been early pioneers in researching stem cell therapy applications for conditions such as cerebral palsy and autism, while conducting multiple clinical trials to evaluate the safety and efficacy of stem cell-based therapies in complex diseases including liver cirrhosis, COPD, bronchopulmonary dysplasia, diabetes, post-traumatic and post-stroke neurological sequelae, and endocrine dysfunction affecting reproductive health, among others.

In addition, Vinmec–VinUni actively researches and applies advanced medical innovations such as CAR-T therapy for hematologic malignancies and personalized 3D printing technologies in surgery to enhance procedural precision and improve patient outcomes. The breadth and depth of research activities reflect Vinmec–VinUni’s strong commitment to addressing emerging medical challenges and developing breakthrough solutions in treatment and healthcare.

Ethical & Safety Commitment

Safety and ethics are the highest priorities in all clinical trials conducted at Vinmec–VinUni. A comprehensive system of Standard Operating Procedures (SOPs) has been established for clinical trial operations, alongside independent ethics committees and rigorous oversight mechanisms. All studies strictly comply with ICH-GCP guidelines and regulatory requirements. Trial participants are treated with respect, provided with transparent and comprehensive information, and receive attentive medical care throughout the study. Vinmec–VinUni conducts all clinical trials with the highest level of responsibility, ensuring the rights, safety, and well-being of research participants.

Strategic Partnerships

Building upon a proven quality foundation, Vinmec–VinUni actively expands international research collaborations. In January 2025, Vinmec and VinUni signed a Memorandum of Understanding with PPD (Thermo Fisher Scientific), one of the world’s leading contract research organizations (CROs) in clinical trials. Under this agreement, Vinmec–VinUni officially became a Select Site within PPD’s global network, participating in advanced clinical trial projects in cell therapy. Being selected by PPD affirms Vinmec–VinUni’s recognized position in clinical research and opens opportunities to collaborate with leading pharmaceutical companies and research centers worldwide.

In addition to PPD, Vinmec maintains extensive international collaborations. Vinmec is proud to be the first hospital system in Vietnam to join the Cleveland Clinic Connected network (USA). Vinmec–VinUni also partners with leading universities such as the University of Pennsylvania and Cornell University (USA) to exchange experts and advance scientific research. These strategic partnerships enable Vinmec–VinUni to leverage global expertise and resources to bring advanced medical solutions closer to Vietnamese patients, while elevating Vietnam’s academic and research standing internationally.

Connecting Research and Practice for a Healthier Future

Vinmec–VinUni is committed to an academic medical ecosystem model, in which the hospital, university, and research centers function as an integrated entity. Long-term, strategic investment in clinical trials has created distinctive core values:

• Quality and Safety: All trials comply with international standards to ensure maximum participant safety.
• Transparency and Ethics: Research information is disclosed transparently; participant rights are protected in accordance with legal and ethical principles.
• Innovation: Proactive adoption of advanced technologies in research and treatment reflects a pioneering spirit to elevate Vietnamese medicine.
• Community Focus: Research prioritizes pressing health challenges in Vietnam, including oncology, cardiovascular diseases, and infectious diseases, delivering meaningful and sustainable benefits to the community.
• International Collaboration: A broad global partnership network mobilizes international expertise and resources to improve healthcare for the Vietnamese population.

Vinmec–VinUni aims to become one of the leading clinical trial centers in the region. With a strong hospital–university model, advanced infrastructure, and an elite professional team, Vinmec–VinUni is contributing to placing Vietnam on the global medical map. The combination of strategic vision and concrete action promises medical breakthroughs, improved healthcare quality, and a healthier, more sustainable future for the community.